Advertisement

Medicolegal and Ethical Issues in the Pharmacologic Treatment of Children

  • Ronald Schouten
  • Kenneth S. Duckworth

Abstract

Physicians who prescribe psychotropic medications to children face unique legal and ethical challenges. The issues of competency, consent to treatment, patient autonomy, and confidentiality are important in this work, just as they are in adult medicine. The child and adolescent psychopharmacologist must also deal with the complex influences of family dynamics, child development, divorce, and custody as well as the involvement of parents, school personnel, and social service agencies in the treatment process. The fact that much remains to be understood in child psychiatry, the probabilistic rather than certain outcomes of medication trials, and the uncertain effects of new treatments on developing nervous systems all add additional layers of complexity.

Keywords

Antipsychotic Medication Tardive Dyskinesia Child Psychiatrist Make Treatment Decision Medical Malpractice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Keeton WP, Dobbs DB, Keeton RE, et al: Prosser & Keeton on Torts, ed 5. St. Paul, Minn, West Publishing Co, 1984.Google Scholar
  2. 2.
    Salgo vs Leland Stanford Jr. Univ. Board of Trustees, 317 P 2d 170 (Calif Ct App), 1957.Google Scholar
  3. 3.
    Natanson vs Kline, 186 Kans 393, 350 P 2d 1093, 1960.Google Scholar
  4. 4.
    Canterbury vs Spence, 464 F 2d 772 (DC Cir), 1972.Google Scholar
  5. 5.
    Jansen AR, Siegler M, Winslade WJ: Clinical Ethics, ed 2. New York, Macmillan, 1986.Google Scholar
  6. 6.
    Scarman L, quoted in Marsh BT: Informed consent: Help or hindrance? J R Soc Med 83:603–606, 1990.Google Scholar
  7. 7.
    Havard JDJ: The responsibility of the doctor. Br Med J 299:503–508, 1989.CrossRefGoogle Scholar
  8. 8.
    Appelbaum PS, Lidz CW, Meisel A: Informed Consent. London, Oxford University Press, 1987.Google Scholar
  9. 9.
    Harnish vs Children’s Hospital Medical Center, 387 Mass 152, 439 NE 2d 240, 1982.Google Scholar
  10. 10.
    Heneghan C: Consent to medical treatment. Lancet 337:421, 1991.PubMedCrossRefGoogle Scholar
  11. 11.
    Popper C: Medical unknowns and ethical consent: Prescribing psychotropic medications for children in the face of uncertainty, in Popper C (ed): Psychiatric Pharmacosciences of Children and Adolescents. Washington DC, American Psychiatric Press, 1987, pp 127–161.Google Scholar
  12. 12.
    Campbell M, Grega DM, Green WH, et al: Neuroleptic-induced dyskinesias in children. Clin Neurophar-macol 6:207–222, 1983.CrossRefGoogle Scholar
  13. 13.
    Gualtieri CT, Barnhill J, McGimsey J, et al: Tardive dyskinesia and other movement disorder in children treated with psychotropic drugs. J Am Acad Child Psychiatry 19:491–510, 1980.PubMedCrossRefGoogle Scholar
  14. 14.
    Beyer HA: Litigation and use of psychoactive drugs in developmental disabilities, in Aman MG, Singh NN (eds): Psychopharmacology of the Developmental Disabilities. Berlin, Springer-Verlag, 29–57, 1988.CrossRefGoogle Scholar
  15. 15.
    Golden GS: Tardive dyskinesia and developmental disabilities, in Aman MG, Singh NN (eds): Psychopharmacology of the Developmental Disabilities. Berlin, Springer-Verlag, 197–215, 1988.CrossRefGoogle Scholar
  16. 16.
    Mallary SD, Gert B, Culver CM: Family coercion and valid consent. Theor Med 7:123–126, 1986.PubMedCrossRefGoogle Scholar
  17. 17.
    Appelbaum PS, Grisso T: Assessing patients’ capacities to consent to treatment. N Engl J Med 319:1635–1638, 1988.PubMedCrossRefGoogle Scholar
  18. 18.
    Brahams D: Consent for treatment of minors in wardship. Lancet1 338:564–565, 1991.CrossRefGoogle Scholar
  19. 19.
    Kessel R: In the U.K., children can’t just say no. Hastings Center Report 23(2):20–21, 1993.PubMedCrossRefGoogle Scholar
  20. 20.
    Dickinson D: Children’s informed consent to treatment: Is the law an ass? J Med Ethics 20:205–206, 222, 1994.CrossRefGoogle Scholar
  21. 21.
    Schleiffer vs Meyers, 644 F 2d 656 (7th Cir), 1981, cert den 454 US 823, 102 S Ct 110.Google Scholar
  22. 22.
    Parham vs J.R., 442 US 584, 1979.Google Scholar
  23. 23.
    R.J.D. vs Vaughan Clinic, P.C., 572 So 2d 1225 (Ala Sup Ct), 1990.Google Scholar
  24. 24.
    In re Roger S., 141 Calif Rptr 298, 569 P 2d 1286 (Calif S Ct), 1977.Google Scholar
  25. 25.
    Corpus Juris Secundum, Parent and Child Sec 16.Google Scholar
  26. 26.
    Hart vs Brown, 29 Conn Sup 368, 289 A 2d 386 (Conn Sup), 1972.Google Scholar
  27. 27.
    Melville vs Sabbatino, 30 Conn Sup 320, 313 A 2d 886 (Conn Sup), 1973.Google Scholar
  28. 28.
    In re Sampson, 65 Mise 2d 658, 317 NYS 2d 641, 1970, aff’d 29 NY 2d 900, 278 NE 2d 918, 1972.Google Scholar
  29. 29.
    In re Green, 448 Pa 338, 292 A 2d 387, 1972.Google Scholar
  30. 30.
    Custody of a Minor, 375 Mass 733, 375 NE 2d 373, 1978.Google Scholar
  31. 31.
    Kluge EH: Informed consent by children: The new reality. Can Med Assoc J 152:1495–1497, 1995.Google Scholar
  32. 32.
    Redding RE: Children’s competence to provide informed consent for mental health treatment. Washington & Lee Law Review 50:695–753, 1993.Google Scholar
  33. 33.
    Koocher GP: Children under the law: The paradigm of consent, in Melton GB (ed): Reforming the Law. New York, Guilford Press, 1987.Google Scholar
  34. 34.
    Holder AR: Disclosure and consent problems in pediatrics. Law Med Health Care 16:219–228, 1988.PubMedGoogle Scholar
  35. 35.
    Corpus Juris Secundum, Parent and Child Sec 5–9.Google Scholar
  36. 36.
    Massachusetts General Laws, Ch 112 Sec 12F.Google Scholar
  37. 37.
    Code of Virginia, Art 15 Sec 16.1–334, 1990.Google Scholar
  38. 38.
    Baird vs Attorney General, 371 Mass 741, 360 NE 2d 288, 1971.Google Scholar
  39. 39.
    Arizona Laws of 1962, Title 44 Sec 44–133.01.Google Scholar
  40. 40.
    Arizona Laws of 1971, Title 44 Sec 44–132.01.Google Scholar
  41. 41.
    Code of Virginia, Art 6 Sec 54.1–2969.Google Scholar
  42. 42.
    Weithorn LA, Campbell SB: The competency of children and adolescents to make informed treatment decisions. Child Dev 53:1589–1598, 1982.PubMedCrossRefGoogle Scholar
  43. 43.
    Dorn LD, Susman EJ, Fletcher JC: Informed consent in children and adolescents: Age, motivation and psychological state. J Adolesc Health 16:185–190, 1995.PubMedCrossRefGoogle Scholar
  44. 44.
    Cauffman E, Steinberg L: The cognitive and affective influences on adolescent decision making. Temple Law Review 68:1763–1789, 1995.Google Scholar
  45. 45.
    American Academy of Pediatrics Committee on Broethics: Informed consent, parental permission, and assent in pediatric practice. Pediatrics 95(2):314–317, 1995.Google Scholar
  46. 46.
    Rogers vs Commissioner of the Department of Mental Health, 390 Mass 489, 458 NE 2d 308, 1983.Google Scholar
  47. 47.
    Appelbaum PS: The right to refuse treatment with antipsychotic medication: Retrospect and prospect. Am J Psychiatry 145:413–419, 1988.PubMedGoogle Scholar
  48. 48.
    Guardianship of Roe, 383 Mass 415, 421 NE 2d 40, 1981.Google Scholar
  49. 49.
    110 Code of Massachusetts Regulations 11.00.Google Scholar
  50. 50.
    Barnum R: Decision making for children: The regulation of psychopharmacological treatment for children in public custody in Massachusetts. Mass Family Law J 7:21–31, 1989.Google Scholar
  51. 51.
    Zummo vs Zummo, 394 Pa S 30, 574 A 2d 1130 (Pa Super), 1990.Google Scholar
  52. 52.
    Durfee vs Durfee, 194 Misc 594, 87 NYS 2d 275 (NY S Ct), 1949.Google Scholar
  53. 53.
    Bernet W: The noncustodial parent and medical treatment. Bull Am Acad Psychiatry Law 21(3):357–364, 1993.PubMedGoogle Scholar
  54. 54.
    Weinstock R, Leong GB, Silva JA: Confidentiality and privilege, in Simon RI (ed): Review of Clinical Psychiatry and the Law. Washington DC, American Psychiatric Association Press, 1990, vol 1, pp 90–98.Google Scholar
  55. 55.
    Coyte PC, Dewees DN, Trebilcock MJ: Medical malpractice—The Canadian experience. N Engl J Med 324:89–93, 1991.PubMedCrossRefGoogle Scholar
  56. 56.
    Danzón PM: The “crisis” in medical malpractice: A comparison of trends in the United States, Canada, the United Kingdom, and Australia. Law Med Health Care 18:48–58, 1990.PubMedGoogle Scholar
  57. 57.
    Quam L, Fenn P, Dingwale R: Medical malpractice in perspective II—The implications for Britain. Br Med J 294:1597–1600, 1987.CrossRefGoogle Scholar
  58. 58.
    Tan MW, McDonough VJ: Risk management in psychiatry. Psychiatric Clin North Am 13:135–147, 1990.Google Scholar
  59. 59.
    Tarasoff vs Regents of University of California, 17 Calif 3d 425, 551 P 2d 334, 1976.Google Scholar
  60. 60.
    Schouten R: Informed consent: Resistance and reappraisal. Crit Care Med 17:1359–1361, 1989.PubMedGoogle Scholar
  61. 61.
    Gutheil TG, Bursztajn H, Brodsky A: Liability prevention through the sharing of uncertainty: Informed consent and the therapeutic alliance. N Engl J Med 311:49–51, 1984.PubMedCrossRefGoogle Scholar
  62. 62.
    Appelbaum PS, Gutheil TG: Clinical Handbook of Psychiatry and the Law. Baltimore, Williams & Wilkins, 1991.Google Scholar
  63. 63.
    Woods vs Brumlop, 377 P 2d 520 (NM), 1962.Google Scholar
  64. 64.
    Gutheil TG: On apologizing to patients. Risk Manage Found Forum 8:3–4, 1987.Google Scholar
  65. 65.
    Weaver vs. Reagen, 886 F. 2d 194 (C.A. 8, 1989).Google Scholar
  66. 66.
    Rayburn WF: A physician’s preogative to prescibe drugs for off-label uses during pregnancy. Obstet Gynecol 81:1052–1055, 1993.PubMedGoogle Scholar
  67. 67.
    Stoffelmayr KJ: Products liability and “off-label” uses of prescription drugs. University of Chicago Law Review 63:275–306, 1996.CrossRefGoogle Scholar
  68. 68.
    American Academy of Pediatrics Committee on Drugs: Unapproved uses of approved drugs: The physician, the package insert, and the Food and Drug Administration: Subject review. Pediatrics 98(1):143–145, 1996.Google Scholar
  69. 69.
    Torres A: The use of Food and Drug Administration-approved medications for unlabelled (off-label) uses. Arch Dermatol 130:32–36, 1994.PubMedCrossRefGoogle Scholar
  70. 70.
    Klein vs. Biscup, 109 Ohio App.3d 855, 673 N.E.2d 225 (Ohio App. 8 Dist).Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Ronald Schouten
    • 1
  • Kenneth S. Duckworth
    • 2
  1. 1.Law and Psychiatry ServiceMassachusetts General HospitalBostonUSA
  2. 2.Massachusetts Mental Health CenterBostonUSA

Personalised recommendations